Wikidata

(Q39668506)

English

Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor

scientific article published on 11 August 2010

In more languages

Statements

title
Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
20702613
retrieved
13 September 2017
author name string
Fabio Pastorino
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
20702613
retrieved
13 September 2017
Monica Loi
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
20702613
retrieved
13 September 2017
Puja Sapra
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
20702613
retrieved
13 September 2017
Pamela Becherini
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
20702613
retrieved
13 September 2017
Michele Cilli
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
20702613
retrieved
13 September 2017
Laura Emionite
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
20702613
retrieved
13 September 2017
Lee M Greenberger
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
20702613
retrieved
13 September 2017
Ivan D Horak
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
20702613
retrieved
13 September 2017
publication date
11 August 2010
1 reference
stated in
Europe PubMed Central
PubMed ID
20702613
retrieved
13 September 2017
page(s)
4809-4821
1 reference
stated in
Europe PubMed Central
PubMed ID
20702613
retrieved
13 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39668506&oldid=1852857808"